Christopher Wolfenberg

Insider Reports History

Entity
Individual
Location
C/O Zomedica Pharmaceuticals Corp, 100 Phoenix Drive, Suite 180, Ann Arbor, MI
Signature
/s/ John Hogoboom, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Wolfenberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zomedica Corp. Director Stock Option (right to buy) 800K May 12, 2021 Direct

Insider Reports Filed by Christopher Wolfenberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZOM Zomedica Corp. May 12, 2021 1 $0 4 May 13, 2021 Director